Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ni, X.
Right arrow Articles by Humphreys, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ni, X.
Right arrow Articles by Humphreys, M. H.

Journal of the American Society of Nephrology, Vol 7, 2110-2118, Copyright © 1996 by American Society of Nephrology


REGULAR ARTICLES

Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation

X Ni, Y Cheng, L Cao, DG Gardner and MH Humphreys
Division of Nephrology, San Francisco General Hospital, CA, USA.

Blunted volume expansion (VE) natriuresis and renal resistance to atrial natriuretic peptide (ANP) characterize states of pathological sodium retention. This study examined rats 1 to 3 wk after common bile- duct ligation (CBDL), at which time they had hyperbilirubinemia and hypoalbuminemia. Sham-operated normal rats (Sham) showed an increased sodium excretion rate (UNaV) from 1.0 +/- 0.1 to 16.3 +/- 3.9 muEq/min in response to acute VE (iv saline, 2 mL/100 g body wt over 5 min), whereas CBDL rats had a blunted response that was apparent after 1 wk and became maximal at 2 and 3 wk (0.3 +/- 0.1 to 3.2 +/- 0.4 muEq/min at 3 wk, P < 0.01 versus Sham response). The peak urinary cGMP excretion rate (UcGMPV) was also blunted (37.9 +/- 3.6 versus 87.5 +/- 8.3 pmol/min, P < 0.01) despite an even greater increase in plasma ANP concentration (Sham, 9.6 +/- 0.4 pg/mL in hydropenia to 22.8 +/- 2.6 pg/mL after VE; CBDL, 15.3 +/- 2.3 to 41.8 +/- 6.8 pg/mL). ANP- dependent cGMP accumulation by isolated inner medullary collecting duct (IMCD) cells from both Sham and CBDL rat kidneys was dose-dependent; however, at higher concentrations of ANP (> 10(-8) M), accumulation by cells from CBDL rats was significantly blunted, indicating resistance to ANP. Binding of 125I-ANP to IMCD cells was not different in CBDL rats compared with Sham control rats. Renal denervation improved but did not completely reverse the blunted natriuresis, and ANP resistance persisted in IMCD cells from denervated kidneys of CBDL rats. Incubation of IMCD cells with the phosphodiesterase inhibitors isomethylbutylxanthine or Zaprinast (each at 10(-3) M) restored ANP responsiveness in both innervated and denervated kidneys from CBDL rats, and intrarenal infusion of Zaprinast (10 micrograms/min) corrected the blunted increase in UNaV and UcGMPV after VE in rats with CBDL. These results suggest that ANP resistance in a model of abnormal sodium metabolism devoid of intrinsic renal disease may be related to increased activity of phosphodiesterase in renal target cells for ANP as well as to heightened renal nerve activity.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Knight, H. Snellen, M. Humphreys, and C. Baylis
Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat
Am J Physiol Renal Physiol, February 1, 2007; 292(2): F655 - F659.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. C. Thiesson, B. L. Jensen, B. Jespersen, O. B. Schaffalitzky de Muckadell, C. Bistrup, S. Walter, P. D. Ottosen, A. Veje, and O. Skott
Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites
Am J Physiol Renal Physiol, May 1, 2005; 288(5): F1044 - F1052.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
X.-P. Ni, M. Safai, R. Rishi, C. Baylis, and M. H. Humphreys
Increased Activity of cGMP-Specific Phosphodiesterase (PDE5) Contributes to Resistance to Atrial Natriuretic Peptide Natriuresis in the Pregnant Rat
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1254 - 1260.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M.-C. Ma, H.-S. Huang, C.-T. Chien, M.-S. Wu, and C.-F. Chen
Temporal decrease in renal sensory responses in rats after chronic ligation of the bile duct
Am J Physiol Renal Physiol, July 1, 2002; 283(1): F164 - F172.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Haloui, D. Messika-Zeitoun, L. Louedec, M. Philippe, and J.-B. Michel
Potentiation of urinary atrial natriuretic peptide interferes with macula densa function
Cardiovasc Res, August 15, 2001; 51(3): 542 - 552.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. C. Casar, A. Valdivieso, J. A. Bravo, C. Chacón, and M. P. Boric
Reduced Natriuresis After Oral Sodium Load in Cholestatic Rats: Role of Compartment Volumes and ANP
Experimental Biology and Medicine, October 1, 2000; 225(1): 23 - 31.
[Abstract] [Full Text]


Home page
HypertensionHome page
H. R. Croxatto, R. Silva, X. Figueroa, R. Albertini, J. Roblero, and M. P. Boric
A Peptide Released by Pepsin From Kininogen Domain 1 Is a Potent Blocker of ANP-Mediated Diuresis-Natriuresis in the Rat
Hypertension, October 1, 1997; 30(4): 897 - 904.
[Abstract] [Full Text]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP